Skip to content

Drug interactions

Idarubicin + Palifermin

Severity: Moderate

Idarubicin and Palifermin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Palifermin stimulates epithelial cell growth, which may make rapidly dividing mucosal cells more vulnerable to cytotoxic drugs. When given close to chemotherapy, it worsened and prolonged oral mucositis.

What this interaction means in plain words

Idarubicin and Palifermin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Idarubicin belongs to Oncology; Palifermin belongs to Miscellaneous.

Evidence level: Moderate

Why it happens

Palifermin-driven epithelial proliferation increases the sensitivity of mucosa to cytotoxic chemotherapy.

What to do

Do not give palifermin within 24 hours before, during, or within 24 hours after idarubicin. Follow the labeled scheduling around chemotherapy.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Idarubicin and Palifermin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Idarubicin with Palifermin?

MediHelp rates the interaction as moderate. Idarubicin and Palifermin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Palifermin stimulates epithelial cell growth, which may make rapidly dividing mucosal cells more vulnerable to cytotoxic drugs. When given close to chemotherapy, it worsened and prolonged oral mucositis.

How serious is the interaction between Idarubicin and Palifermin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not give palifermin within 24 hours before, during, or within 24 hours after idarubicin. Follow the labeled scheduling around chemotherapy.

What other medicines interact with Idarubicin?

MediHelp also lists interactions of Idarubicin with, for example, Adenovirus types 4 and 7 live, Belatacept, Cyclophosphamide. The full list is on the Idarubicin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in